Results 221 to 230 of about 53,199 (230)

Bortezomib Formulations

2012
USAYAPANT ARUNYA, BOWMAN DAVID
openaire   +2 more sources

Bortezomib in recurrent and/or refractory multiple myeloma

Cancer, 2005
Robert Z Orlowski, Paul Richardson
exaly  

Bortezomib in Multiple Myeloma: Systematic Review and Clinical Considerations

Current Oncology, 2014
M C Cheung, D E Reece
exaly  

Bortezomib

Reactions Weekly
openaire   +1 more source

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

European Journal of Haematology, 2006
Maria Teresa Cibeira Lopez, Olga Salamero   +1 more
exaly  

Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer

Biochemical Pharmacology, 2012
Yehuda G Assaraf, Jacqueline Cloos, Frank Kruyt   +2 more
exaly  

Bortezomib

Reactions Weekly, 2017
openaire   +2 more sources

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma

Cancer, 2016
Roman Hajek, Pieter Sonneveld, Tadeusz Robak   +2 more
exaly  

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

British Journal of Haematology, 2004
exaly  

Subcutaneous Bortezomib

Drugs, 2013
exaly